20th- 22nd October 2021

5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference (Time Zone - Eastern Standard Time (EST)

MarketsandMarkets is proud to announce the 5th Edition Real-World Data, Life Sciences Analytics and Market Access Virtual Conference to be held on October 20-22, 2021. The expanding utilization of Real World Evidence to speed up data driven choices is further developing the clinical trial experience, but healthcare in general. 

While there is extraordinary promise in utilizing Real World Data and Real World Evidence, there are some significant challenges that should be survived: potential bias of information and data sources, inadequate data sets and absence of harmonization of data between RWE data sources, access to such data, and lack of standards in evaluating the worth of Real World Evidence data. Further developing RWE is key for pharma organizations in drug development. There was big data available pre covid and now with the access data due to covid, technology enablers like AI and ML are important for big data analysis and evidence generation. Every stakeholder has faced a some impact and had to adjust. 

users

Learn how adoption of real-world evidence can be accelerated across pharmaceutical industry

users

Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research

users

Understand the impact of innovative real-world evidence partnerships for better data

This conference will focus on above said significant challenges and hold discussion on the best practices adopted by various stakeholders with a key takeaway being better decision making. 

WHAT TO EXPECT
Key Highlights
  • Clinical trial protocol design
  • Impact of covid on clinical trial design
  • Patients focussed drug development
  • Reimbursement schemes during the era of covid- Has it changed?
  • Partnering strategies
  • Technology enablers-Artificial Intelligence and Machine Learning for big data analytics
  • RWE in rare diseases space helping to achieving the required approvals
  • Patient identification- An important aspect of real world evidence
Why Attend?
  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators, and solution providers
Who Should Attend?

From Pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologists, within the following departments-

  • Real-World Evidence
  • Health Economics & Outcomes Research
  • Market Access
  • Value Access
  • Clinical Outcomes
  • Clinical Development
  • Center for Observational and Real-World Evidence  
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Nneka Onwudiwe

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer
FOOD AND DRUG ADMINISTRATION

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer
FOOD AND DRUG ADMINISTRATION
David Miller

David Miller

Executive Director, Head of RWE- Patient Safety
Sarepta Therapeutics, USA

David Miller

Executive Director, Head of RWE- Patient Safety
Sarepta Therapeutics, USA
Speakers
Andrew Larsen

Andrew Larsen

Director of Life Sciences Partnership
PicnicHealth

Andrew Larsen

Director of Life Sciences Partnership
PicnicHealth
Tao Fan

Tao Fan

Senior Director, US HEOR US Medical Office
Takeda Pharmaceuticals

Tao Fan

Senior Director, US HEOR US Medical Office
Takeda Pharmaceuticals
Aparna Mangari

Aparna Mangari

Head Data Science and Analytics
Novartis

Aparna Mangari

Head Data Science and Analytics
Novartis
Nneka Onwudiwe

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer
FOOD AND DRUG ADMINISTRATION

Nneka Onwudiwe

Former PRO/PE Regulatory Review Officer
FOOD AND DRUG ADMINISTRATION
Melva Covington

Melva Covington

Senior Vice President, Research and Patient Outcomes
Curio Digital Therapeutics

Melva Covington

Senior Vice President, Research and Patient Outcomes
Curio Digital Therapeutics
David Miller

David Miller

Executive Director, Head of RWE- Patient Safety
Sarepta Therapeutics, USA

David Miller

Executive Director, Head of RWE- Patient Safety
Sarepta Therapeutics, USA
Marla Curran

Marla Curran

VP, Head of Biometrics and Medical WritinG
Rafael Pharmaceuticals

Marla Curran

VP, Head of Biometrics and Medical WritinG
Rafael Pharmaceuticals
Michelle Bridenbaker

Michelle Bridenbaker

Global Medical Information Lead
Idorsia Pharmaceuticals

Michelle Bridenbaker

Global Medical Information Lead
Idorsia Pharmaceuticals
SPONSORS
Platinium
example-image

Picnic Health

example-image

Dedalus

example-image

OM1

Silver
example-image

Komodo Health

Sponsors & Exhibitors
example-image

Premier Inc.

Speaking Partner
example-image

RTI Health Solutions

example-image

Aetion

example-image

LynxCare

PARTNERS
Supporting Association
Institute of Analytics

Institute of Analytics

Digital Analytics Association

Digital Analytics Association

Media Partners
example-image

HealthEconomics.Com

example-image

This Week in Digital Health

PAST EVENT GALLERY